In a filing, Regenxbio Inc revealed its Director Mills Kenneth T. unloaded Company’s shares for reported $0.16 million on May 12 ’25. In the deal valued at $7.91 per share,20,602 shares were sold. As a result of this transaction, Mills Kenneth T. now holds 475,103 shares worth roughly $3.85 million.
Then, KENNETH MILLS bought 20,602 shares, generating $154,927 in total proceeds.
Before that, VITTAL VASISTA bought 20,041 shares. Regenxbio Inc shares valued at $148,504 were divested by the Officer at a price of $7.41 per share.
Goldman downgraded its Regenxbio Inc [RGNX] rating to a Neutral from a a Buy in a research note published on February 11, 2025; the price target was decreased to $14 from $38.
Price Performance Review of RGNX
On Tuesday, Regenxbio Inc [NASDAQ:RGNX] saw its stock jump 8.58% to $8.1. Over the last five days, the stock has lost -2.29%. Regenxbio Inc shares have fallen nearly -31.88% since the year began. Nevertheless, the stocks have risen 4.79% over the past one year. While a 52-week high of $13.48 was reached on 06/02/25, a 52-week low of $5.03 was recorded on 04/09/25.
Levels Of Support And Resistance For RGNX Stock
The 24-hour chart illustrates a support level at 7.71, which if violated will result in even more drops to 7.32. On the upside, there is a resistance level at 8.31. A further resistance level may holdings at 8.52.
How much short interest is there in Regenxbio Inc?
A steep rise in short interest was recorded in Regenxbio Inc stocks on 2025-07-31, dropping by -0.65 million shares to a total of 5.48 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 6.13 million shares. There was a decline of -11.78%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 07, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $38 price target.
